These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2900201)

  • 1. Somatostatin structure-activity studies in the stomach.
    Hirst BH; Botana LM; Arilla E; Coy DH
    Horm Res; 1988; 29(2-3):79-82. PubMed ID: 2900201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic hexa- and pentapeptide somatostatin analogues with reduced gastric inhibitory activity.
    Hirst BH; Arilla E; Coy DH; Shaw B
    Peptides; 1984; 5(5):857-60. PubMed ID: 6150467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity studies with somatostatin: role of lysine in positions 4 and 9 for gastric activity.
    Hirst BH; Coy DH
    Regul Pept; 1984 Jul; 8(4):267-71. PubMed ID: 6149602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of eighteen somatostatin analogues on gastric secretion.
    Brown MP; Coy DH; Gomez-Pan A; Hirst BH; Hunter M; Meyers C; Reed JD; Schally AV; Shaw B
    J Physiol; 1978 Apr; 277():1-14. PubMed ID: 349135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release.
    Rossowski WJ; Gu ZF; Akarca US; Jensen RT; Coy DH
    Peptides; 1994; 15(8):1421-4. PubMed ID: 7535424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of somatostatin analogs on gastric acid secretion in dogs and rats.
    Schally AV; Colaluca J; Paulson D; Carter WH; Neitzschman HR; Lafaye H; Cai RZ
    Int J Pept Protein Res; 1990 Sep; 36(3):267-74. PubMed ID: 1980670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies with somatostatin: the role of tryptophan in position 8.
    Hirst BH; Shaw B; Meyers CA; Coy DH
    Regul Pept; 1980 Oct; 1(2):97-113. PubMed ID: 6114515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man.
    Whitehouse I; Beglinger C; Fried M; Gyr K
    Hepatogastroenterology; 1984 Oct; 31(5):227-9. PubMed ID: 6150888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric mucosal protection by somatostatins.
    Kusterer K; Rohr G; Schwedes U; Usadel KH; Szabo S
    Klin Wochenschr; 1986; 64 Suppl 7():97-9. PubMed ID: 2882058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociated effects of somatostatin on gastric acid secretion and mucosal blood flow.
    Leung FW; Guth PH
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G337-41. PubMed ID: 2858159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin.
    Konturek SJ; Tasler J; Cieszkowski M; Coy DH; Schally AV
    Gastroenterology; 1976 May; 70(5 PT.1):737-41. PubMed ID: 1261766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats.
    Lloyd KC; Wang J; Aurang K; Grönhed P; Coy DH; Walsh JH
    Am J Physiol; 1995 Jan; 268(1 Pt 1):G102-6. PubMed ID: 7840190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential somatostatin and gastrin releases in response to secretin in rat in vivo.
    Rigaud D; Dubrasquet M; Accary JP; Laigneau JP; Lewin MJ
    Gastroenterol Clin Biol; 1991; 15(10):717-22. PubMed ID: 1687737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gastric and pancreatic secretion in dogs by CGRP: role of somatostatin.
    Helton WS; Mulholland MM; Bunnett NW; Debas HT
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G715-20. PubMed ID: 2565089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of GRP on beta-adrenergic-stimulated gastrin and somatostatin release in the isolated rat stomach.
    Short GM; Reel GM; Doyle JW; Wolfe MM
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G197-202. PubMed ID: 2862794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat.
    Hirst BH; Reed JD; Shaw B; Coy DH; Schally AV
    Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):208-12. PubMed ID: 352081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin type A receptors mediate intestinal fat-induced inhibition of acid secretion through somatostatin-14 in dogs.
    Fung L; Pokol-Daniel S; Greenberg GR
    Endocrinology; 1994 Jun; 134(6):2376-82. PubMed ID: 7910794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2).
    Li P; Chang TM; Coy D; Chey WY
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G121-7. PubMed ID: 10644570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
    Bado A; Cloarec D; Moizo L; Laigneau JP; Bataille D; Lewin MJ
    Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.